The curcumin analog (PAC) suppressed cell survival and induced apoptosis and autophagy in oral cancer cells

@article{Semlali2021TheCA,
  title={The curcumin analog (PAC) suppressed cell survival and induced apoptosis and autophagy in oral cancer cells},
  author={Abdelhabib Semlali and Camille Contant and Basem Al-Otaibi and ibrahim al-jammaz and Fatiha Chandad},
  journal={Scientific Reports},
  year={2021},
  volume={11},
  url={https://api.semanticscholar.org/CorpusID:235333887}
}
It is demonstrated that PAC preferentially and, in a dose, -dependent way kills oral cancer cells, but was not toxic to normal human gingival cells, suggesting the potential use of PAC to treat oral cancer.
View on Springer
nature.com
42 Citations
Background Citations
12
Methods Citations
6
Results Citations
2

42 Citations

MTH-3 sensitizes oral cancer cells to cisplatin via regulating TFEB.

MTH-3 induces autophagy and apoptosis of CAR cells via TFEB and might be an effective pharmacological agent for treating oral cancer cells.

Rapamycin inhibits oral cancer cell growth by promoting oxidative stress and suppressing ERK1/2, NF-κB and beta-catenin pathways

The results indicate that rapamycin could be a potential agent for the treatment of oral cancer and for a prevention strategy through inhibition of several cancer-promoting pathways (MAPK, NF-κB, and Wnt/beta-catenin).

The Curcumin Analog PAC Is a Potential Solution for the Treatment of Triple-Negative Breast Cancer by Modulating the Gene Expression of DNA Repair Pathways

Investigation of the effect of the curcumin-analog PAC on DNA repair pathways in MCF-7 and MDA-MB-231 human breast-cancer cell lines suggests that PAC increases involvement of multiple genes in a DNA repair pathway, which can open a new perspective in breast- cancer treatment.

The curcumin analogue PAC has potent anti-anaplastic thyroid cancer effects

It is shown that PAC induces apoptosis in thyroid cancer cells in a time-dependent fashion through the mitochondrial pathway, and that PAC could be considered as promising therapeutic agent for anaplastic thyroid carcinomas.

Magnolol Triggers Caspase-Mediated Apoptotic Cell Death in Human Oral Cancer Cells through JNK1/2 and p38 Pathways

The current study supports the role for magnolol as a therapeutic approach for oral cancer through JNK1/2- and p38-mediated caspase activation through the c-Jun N-terminal kinase (JNK) 1/2 and p 38 pathways.

Modulation of signature cancer-related genes in oral cancer cells (Ca9-22) by anethole treatment: Insights into therapeutic potential

The study suggests that anethole holds promise as a potential alternative treatment for oral cancer by its ability to modify numerous oncogenes and tumor suppressor genes implicated in the cell cycle regulation and induction of apoptosis in oral cancer cells.

Cellular mechanisms mediating the anti-cancer effects of carnosol on gingiva carcinoma

Overall, carnosol mediated colony formation and proliferation suppression in addition to cytotoxicity induction in addition to cytotoxicity induction, and reduced inflammation and invasion ability by modulating IL-6 and MMP9/TIMP-1 axes.

L48H37, a curcumin analog, suppresses matrix metalloproteinase-9 expression and activity to hamper nasopharyngeal cancer cell migration.

Curcumin analog HO‐3867 triggers apoptotic pathways through activating JNK1/2 signalling in human oral squamous cell carcinoma cells

The results suggest that HO‐3867 is an effective anticancer agent as its induction of cell apoptosis through JNK1/2 pathway in human oral cancer cells.

Curcumin: a bioactive compound with molecular targets for human malignancies

Curcumin inhibits tumour development and metastasis by inhibiting many pathways that regulate signalling in malignant cells, including Ras, p53, extracellular signal-regulated kinases (ERK), Wnt-protein kinase B (Akt), MAPKs, and PI3K.

62 References

PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells

Results indicate that PAC could constitute a powerful, yet not toxic, new chemotherapeutic agent against ER-negative breast tumours and exhibited higher stability in blood and greater biodistribution and bioavailability than curcumin in mice.

PAC exhibits potent anti‐colon cancer properties through targeting cyclin D1 and suppressing epithelial‐to‐mesenchymal transition

Results indicate that PAC has potent anti‐CRC effects, and therefore could constitute an effective alternative chemotherapeutic agent, which may consolidate the adjuvant treatment of colon cancer.

Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma

An overview of the current in vitro and in vivo data supporting its therapeutic activity in head and neck cancer as well as some of the challenges concerning its development as an adjuvant chemotherapeutic agent are presented.

A novel sulfonyl chromen‐4‐ones (CHW09) preferentially kills oral cancer cells showing apoptosis, oxidative stress, and DNA damage

A sulfonyl substituent to chromen‐4‐one skeleton is installed and synthesized CHW09 to evaluate its antioral cancer effect in terms of cell viability, cell cycle, apoptosis, oxidative stress, and DNA damage.

Cracking the Cytotoxicity Code: Apoptotic Induction of 10-Acetylirciformonin B is Mediated through ROS Generation and Mitochondrial Dysfunction

10AB-induced apoptosis is mediated through the overproduction of ROS and the disruption of mitochondrial metabolism, suggesting that ROS overproduction plays a crucial rule in the cytotoxic activity of 10AB.

Potential anticancer properties and mechanisms of action of curcumin.

The ability of curcumin to induce apoptosis in tumor cells and its anti-angiogenic potential will be discussed in this review.

Does scavenging of mitochondrial superoxide attenuate cancer prosurvival signaling pathways?

The data lead to the hypothesis that scavenging of mitochondrial superoxide selectively inhibits redox-sensitive survival and metabolic pathways, resulting in cancer cell death.

KCP10043F Represses the Proliferation of Human Non-Small Cell Lung Cancer Cells by Caspase-Mediated Apoptosis via STAT3 Inactivation

The data suggest that KCP10043F suppresses NSCLC cell growth through apoptosis induction via STAT3 inactivation and binds to a pocket in the SH2 domain of STAT3 and prevents STAT3 phosphorylation.

Perspectives on new synthetic curcumin analogs and their potential anticancer properties.

A summarized account of novel synthetic curcumin formulations and analogs, and the recent progress in the field of cancer prevention and treatment is provided.

Developments in the anticancer activity of structurally modified curcumin: An up-to-date review.

...